This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Protocol describes high-throughput screening of 2,500 peptides from 20 animal venoms against colorectal cancer cell lines, with plans to isolate and characterize the most potent anti-CRC peptides.
Why it matters
Colorectal cancer is a leading cause of cancer death. Current treatments have significant side effects. Venom-derived peptides could provide targeted cancer-killing agents with different mechanisms than existing drugs.
The numbers in context
2,500 peptides; 20 venoms; 3 CRC cell lines; 2 control cell lines; MTT assay; top 3 venoms for peptide isolation
How the study worked
Proof-of-concept protocol. Will screen 2,500 peptides from 20 venoms using MTT cytotoxicity assay against 3 CRC cell lines and 2 control cell lines. Top 3 venoms will be further fractionated to identify specific anti-cancer peptides.
Who was studied
Protocol for screening venom peptides against colorectal cancer cell lines (no results yet)
What this study cannot tell us
Protocol only. No results available. Cell line screening does not predict clinical efficacy. The specificity of venom peptides in living organisms may differ from cell culture results.
Read the original research
A Venomics Approach to the Identification and Characterization of Bioactive Peptides From Animal Venoms for Colorectal Cancer Therapy: Protocol for a Proof-of-Concept Study.
JMIR research protocols, 10(12), e31128
Citation
Shahzadi, Syeda Kiran; Karuvantevida, Noushad; Banerjee, Yajnavalka. (2021). A Venomics Approach to the Identification and Characterization of Bioactive Peptides From Animal Venoms for Colorectal Cancer Therapy: Protocol for a Proof-of-Concept Study.. JMIR research protocols, 10(12), e31128. https://doi.org/10.2196/31128